| 000 | 013720000a22003370004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025137.0 | ||
| 008 | 080124s2007 ua f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.15.M.Sc.2007.Ho.H | ||
| 100 | 0 | _aHoda Abdelrahman Albadry | |
| 245 | 1 | 0 |
_aHuman papillomavirus vaccine / _cHoda Abdelrahman Albadry ; Supervised Ahmed Mahmoud Elmanawi , Neiven Kamal Alghamry |
| 246 | 1 | 5 | _aلقاح ضد الفيروس العنقودى |
| 260 |
_aCairo : _bHoda Abdelrahman Albadry , _c2007 |
||
| 300 |
_a244P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Gynecology and Obstetrics | ||
| 520 | _aCervical cancer and prccancerous lesions of the genital tract are major threats to the health of women worldwide.The introduction of screening tests to detect cervical cancer precursor lesions has reduced cervical cancer rates in the developed world | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCervical | |
| 653 | 4 | _aHuman papillomavirus | |
| 653 | 4 | _aVaccine | |
| 700 | 0 |
_aAhmed Mahmoud Elmanawi , _eSupervisor |
|
| 700 | 0 |
_aNeiven Kamal Alghamry , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEsam _eRevisor |
||
| 905 |
_aNazla _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c6567 _d6567 |
||